Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol versus custodiol + modified del Nido for myocardial protection in CABG surgery
IRCT20190411043239N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2019
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label trial of HTK Custodiol and del Nido cardioplegia in coronary arteriosclerosis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Serum CK-MB level and Serum troponin level. Started Jun 2019; status: completed.
02
Drugs
HTK Custodioldel Nido cardioplegia
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20190411043239N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190411043239N1.